| Epithelioid Hemangioendothelioma studied in …STUDIED_INderived12 of 12show fewer |
|---|
| → studied in | NCT03331250Phase 2 · completed Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684287Phase 2 · not yet recruiting A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07104331Phase 2 · recruiting SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06408441recruiting The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967834NA · recruiting Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ALIAS · 12 trials mapped (7 active) | — | — | Liver Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03148275Phase 2 · completed Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228015Phase 1 · terminated Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06452160Phase 1 · recruiting A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Adult Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (7 active) | — | — | Adult Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |